Loading clinical trials...
Loading clinical trials...
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Opioid Withdrawal
Conditions
Interventions
Buspirone
Lofexidine
+1 more
Locations
1
United States
Behavioral Pharmacology Research Unit
Baltimore, Maryland, United States
Start Date
December 15, 2022
Primary Completion Date
January 31, 2027
Completion Date
March 31, 2027
Last Updated
January 7, 2026
NCT04587791
NCT07421102
NCT05492825
NCT05942313
NCT07466784
NCT06651177
Lead Sponsor
Johns Hopkins University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions